Sitagliptin phosphate and metformin hydrochloride (500 mg)

Sitagliptin phosphate and metformin hydrochloride (500 mg)
GLISITAPTIN M is a combination medication that helps to manage type 2 diabetes. Sitagliptin phosphate belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which help increase insulin production and decrease the amount of glucose produced by the liver. Metformin hydrochloride, on the other hand, helps reduce glucose production by the liver and improves insulin sensitivity in the body.
GLISITAPTIN M is taken orally, usually twice daily, with meals. The dosage may be adjusted based on individual response to the medication. It is important to take this medication regularly and as prescribed by a healthcare professional, even if you are feeling well.
Common side effects of the GLISITAPTIN M may include headache, nausea, vomiting, diarrhea, and upper respiratory tract infection. It may also cause changes in blood sugar levels or increase the risk of pancreatitis, a rare but serious inflammation of the pancreas. More serious side effects are rare but may include kidney problems or allergic reactions. If you experience any of these symptoms, you should seek medical attention immediately.
GLISITAPTIN M is available in strengths of 500 & 1000 mg.
For further information please contact:
info@sterispharma.com